P1336: ANTIVIRAL EXPOSURE TO GANCICLOVIR AND VALGANCICLOVIR IS NOT ASSOCIATED WITH INCREASED INCIDENCE OF RELAPSE OR SECONDARY MALIGNANCIES IN HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENTS.

Autor: Duarte, D., Duarte, S., Sol dos Reis, C., Silva Coelho, P., Leite, L., Branca, R., Roncon, S., Pinho Vaz, C., Campos, A.
Zdroj: HemaSphere; 2022 Supplement 3, Vol. 6, p1221-1222, 2p
Databáze: Complementary Index
Externí odkaz: